Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Wellgistics Health (WGRX) Cost of Revenue (2024 - 2025)

Wellgistics Health filings provide 2 years of Cost of Revenue readings, the most recent being -$19.0 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 270.34% to -$19.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.9 million, a N/A change, with the full-year FY2025 number at $1.2 million, down 92.52% from a year prior.
  • Cost of Revenue hit -$19.0 million in Q4 2025 for Wellgistics Health, down from $803747.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $11.2 million in Q4 2024 to a low of -$19.0 million in Q4 2025.